Comerica (CMA - Get Report) was upgraded to neutral from underperform at Bank of America/Merrill Lynch. $70 price target. The company has strong earnings leverage to higher interest rates, analysts said.
Heico (HEI - Get Report) was upgraded to outperform from neutral at Credit Suisse. $86 price target. The company generates consistent free-cash flow, which should be augmented by recent acquisitions, Credit Suisse said.
Halyard (HYH) was downgraded to hold from buy at Deutsche Bank. $35 price target. 2017 will likely be another transitional year, Deutsche said.
Swift (SWFT) was upgraded to overweight from neutral at J.P. Morgan. $31 price target. The company is leveraged to a turn in the truckload cycle, J.P. Morgan said.
Valeant Pharmaceuticals (VRX) was downgraded to equal-weight from overweight at Morgan Stanley. $17 price target. Earnings estimates were also cut, given weaker business trends, Morgan said.